Linkage of cognitive impairments with metabolic disorders in schizophrenia.
Nasrallah
Henry A
HA
D014150:Antipsychotic Agents / Q000627:therapeutic use; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D015897:Comorbidity; D055808:Drug Discovery; D006801:Humans; D008659:Metabolic Diseases / Q000175:diagnosis* / Q000453:epidemiology*; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000453:epidemiology; D050177:Overweight / Q000175:diagnosis / Q000453:epidemiology; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents